Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025)
Invivyd (IVVD) posted Other Accumulated Expenses of $52000.0 for Q4 2025, up 62.5% on a QoQ basis from $32000.0 in Q3 2025, and up 92.59% year-over-year from $27000.0 in Q4 2024.
Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025) Analysis & Trends
Invivyd's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $52000.0 for Q4 2025.
- Quarterly Other Accumulated Expenses rose 92.59% year-over-year to $52000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52000.0 (up 92.59% YoY) and the FY2025 annual result came in at $52000.0, up 92.59% from the prior year.
- Other Accumulated Expenses was $52000.0 for Q4 2025 at Invivyd, up from $32000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $58000.0 in Q2 2022 and bottomed at $20000.0 in Q3 2024.
- A 4-year average of $37666.7 and a median of $35000.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses sank 49.06% — and 2025, when it surged 92.59%.
- Invivyd's Other Accumulated Expenses stood at $44000.0 in 2022, then decreased by 20.45% to $35000.0 in 2023, then declined by 22.86% to $27000.0 in 2024, then jumped by 92.59% to $52000.0 in 2025.
- Business Quant data shows IVVD's Other Accumulated Expenses at $52000.0 in Q4 2025, $32000.0 in Q3 2025, and $26000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 58,000.00 |